Literature DB >> 11479841

Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro.

M P Michalsky1, A Kuhn, V Mehta, G E Besner.   

Abstract

BACKGROUND/
PURPOSE: The production of heparin-binding EGF-like growth factor (HB-EGF) is upregulated during organ injury and has a cytoprotective effect during hypoxic stress in intestinal epithelial cells in vitro and intestinal ischemia-reperfusion injuries in vivo. The purpose of this study was to determine if HB-EGF-related cytoprotection is manifested through alterations in apoptosis.
METHODS: Human intestinal epithelial cell monolayers (DLD-1 and Caco-2) were stimulated with interleukin (IL)-1 (20 ng/mL), tumor necrosis factor (TNF)-alpha (40 ng/mL), and interferon (IFN)-gamma (10 ng/mL) with or without HB-EGF (1, 10 or 100 ng/mL) and analyzed for rates of apoptosis utilizing a Cell Death Detection ELISA and flow cytometry.
RESULTS: ELISA results showed a 3-fold increase in the level of apoptosis during stimulation with cytokines compared with nonstimulated cells (P <.05). Relative levels of cytokine induced apoptosis were reduced after 12 hours of HB-EGF exposure (P <.05) in a dose-dependent fashion. Results of flow cytometric analysis also showed a reduction in apoptosis at 6 hours when cell monolayers were stimulated with cytokines in conjunction with HB-EGF compared with cytokines alone (P <.05).
CONCLUSIONS: HB-EGF downregulated apoptosis in intestinal epithelial cells exposed to proinflammatory cytokines in vitro. The results of this study suggest that alterations in apoptosis may represent a possible mechanism by which this growth factor exerts its cytoprotective effect at the mucosal level during the proinflammatory state. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479841     DOI: 10.1053/jpsu.2001.25730

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  20 in total

1.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium.

Authors:  Timothy M Nolan; Nick DiGirolamo; Nitin H Sachdev; Taline Hampartzoumian; Minas T Coroneo; Denis Wakefield
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

2.  Heparin-binding EGF-like growth factor protects pericytes from injury.

Authors:  Xiaoyi Yu; Andrei Radulescu; Chun-Liang Chen; Iyore O James; Gail E Besner
Journal:  J Surg Res       Date:  2010-09-17       Impact factor: 2.192

Review 3.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

4.  Heparin-binding epidermal growth factor-like growth factor restores Wnt/β-catenin signaling in intestinal stem cells exposed to ischemia/reperfusion injury.

Authors:  Chun-Liang Chen; Jixin Yang; Iyore O A James; Hong-Yi Zhang; Gail E Besner
Journal:  Surgery       Date:  2014-02-06       Impact factor: 3.982

5.  EGF receptor plays a role in the mechanism of glutamine-mediated prevention of alcohol-induced gut barrier dysfunction and liver injury.

Authors:  Avtar S Meena; Pradeep K Shukla; Parimal Sheth; RadhaKrishna Rao
Journal:  J Nutr Biochem       Date:  2018-11-06       Impact factor: 6.048

6.  HB-EGF improves intestinal microcirculation after hemorrhagic shock.

Authors:  Hong-yi Zhang; Andrei Radulescu; Yan Chen; Gail E Besner
Journal:  J Surg Res       Date:  2010-02-11       Impact factor: 2.192

7.  Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice.

Authors:  Hong-Yi Zhang; Andrei Radulescu; Gail E Besner
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

8.  Expression of heparin-binding EGF-like growth factor in term chorionic villous explants and its role in trophoblast survival.

Authors:  A N Imudia; B A Kilburn; A Petkova; S S Edwin; R Romero; D R Armant
Journal:  Placenta       Date:  2008-08-08       Impact factor: 3.481

9.  Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects.

Authors:  Jixin Yang; Yanwei Su; Yu Zhou; Gail E Besner
Journal:  Pathophysiology       Date:  2013-12-15

10.  Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis.

Authors:  Xiaoyi Yu; Andrei Radulescu; Nicholas Zorko; Gail E Besner
Journal:  Gastroenterology       Date:  2009-04-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.